Time until modification of antiparkinsonian therapy in a group of patients from Colombia

CONCLUSIONS: After five years of treatment, 63.5% of the patients with Parkinson's disease required modifications to their therapy, with a mean time of three years. Male sex, age over 65 years, and receiving initial therapy with amantadine affected the likelihood of switching therapy in these patients in Colombia.PMID:36544370 | DOI:10.33588/rn.7601.2022162

Source: Revista de Neurologia - December 22, 2022 Category: Neurology Authors: A Valencia-V ásquez A Gaviria-Mendoza J D Ayala-Torres F Calvo-Torres J E Machado-Alba Source Type: research